Community in the GLP-1 space isnt just nice to have
25% lost more than 10%) Significant reductions in CRP and triglyceride levels Improvement in pain scores Improvement in DAPSA (Disease Activity in PsA) scores Improvement in patient global assessment This is exactly what Id watched happen with Daniel except now there is published data behind it
Cell-mediated immunity refers to all immune responses that are not antibody-driven (such as the activation of macrophages, the activation of natural killer cells, and cytokines that respond to antigens rather than antibodies)
Understanding why these effects occur can help in managing them better
In April 2025, according to an article published by the Heart Rhythm Society, a recent clinical study, TRANSFORM-AF, found that GLP-1 receptor agonists (GLP-1 RAs), typically used for diabetes, may reduce atrial fibrillation (AF)-related events in patients with both obesity and AF
238 studied genes related to glutaminolysis in order to determine the sensitivity of glutamine metabolism to xCT-targeted therapy in head and neck squamous cell carcinoma
